share_log

和鉑醫藥-B：獨立非執行董事辭任及董事會委員會組成變動

HBM HOLDINGS-B: RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR ANDCHANGES IN COMPOSITION OF BOARD COMMITTEES

Hong Kong Stock Exchange ·  Jun 21 18:51
Summary by Futu AI
和鉑醫藥控股有限公司宣布，邱家賜先生將於2024年6月21日辭去獨立非執行董事、審核委員會主席及薪酬委員會成員的職務。邱先生表示辭任是為了專注於個人事業，並無與董事會有任何意見分歧。董事會對邱先生在任內的貢獻表示感謝。隨著邱先生的離職，葉小平博士和Albert R. Collinson博士將接替其在委員會中的職位。然而，邱先生的辭任導致公司暫時未能滿足香港聯合交易所有限公司上市規則中對獨立非執行董事的專業資格要求。公司正在尋找合適的人選以符合相關規定，並將在三個月內作出相應的人事調整。
和鉑醫藥控股有限公司宣布，邱家賜先生將於2024年6月21日辭去獨立非執行董事、審核委員會主席及薪酬委員會成員的職務。邱先生表示辭任是為了專注於個人事業，並無與董事會有任何意見分歧。董事會對邱先生在任內的貢獻表示感謝。隨著邱先生的離職，葉小平博士和Albert R. Collinson博士將接替其在委員會中的職位。然而，邱先生的辭任導致公司暫時未能滿足香港聯合交易所有限公司上市規則中對獨立非執行董事的專業資格要求。公司正在尋找合適的人選以符合相關規定，並將在三個月內作出相應的人事調整。
PuraPharm Corporation announced that Mr. Chi Ka Chi will resign from his position as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee on June 21, 2024. Mr. Chi stated that his resignation was to focus on personal pursuits and was not due to any disagreement with the Board of Directors. The Board of Directors expressed their gratitude for Mr. Chi's contributions during his tenure. With Mr. Chi's departure, Dr. Yip Siu Ping and Dr. Albert R. Collinson will take over his positions on the committee. However, Mr. Chi's resignation has temporarily caused the company to fail to meet the professional qualifications required by the Listing Rules of the Hong Kong Stock Exchange for independent non-executive directors. The company is looking for suitable candidates to comply with relevant regulations and will make appropriate personnel adjustments within three months.
PuraPharm Corporation announced that Mr. Chi Ka Chi will resign from his position as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee on June 21, 2024. Mr. Chi stated that his resignation was to focus on personal pursuits and was not due to any disagreement with the Board of Directors. The Board of Directors expressed their gratitude for Mr. Chi's contributions during his tenure. With Mr. Chi's departure, Dr. Yip Siu Ping and Dr. Albert R. Collinson will take over his positions on the committee. However, Mr. Chi's resignation has temporarily caused the company to fail to meet the professional qualifications required by the Listing Rules of the Hong Kong Stock Exchange for independent non-executive directors. The company is looking for suitable candidates to comply with relevant regulations and will make appropriate personnel adjustments within three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.